泰林生物 (300813)
ZheJiang Tailin Bioengineering Co.,Ltd
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 12119.92
- Circulating A-Shares(W): 7605.11
- Earnings Per Share(RMB): 0.1200
- Net Assets Per Share(RMB): 6.5194
- Operating Revenue(W RMB): 21318.89
- Total Profit(W RMB): 1507.56
- Net Profit Attributable to Parent(W RMB): 1472.33
- Net Profit Growth Rate(%): 30.13
- Weighted Return on Equity(%): 1.8200
- Operating Cash Flow Per Share(RMB): 0.1230
- Undistributed Profit Per Share(RMB): 1.9904
- Capital Reserve Per Share(RMB): 3.3933
2. Main Business
The main business covers:
- Microbial detection and contamination control in life sciences
- Innovative drug research, development, and production
- Research, production, and promotion of process analysis and containment protection products
- Providing high-quality products and solutions for industries such as biopharmaceuticals, healthcare, food & beverage, and environmental protection
3. Company Basic Information
- Company Name: Zhejiang Tailin Bioengineering Co., Ltd.
- Listing Date: 2020-01-14
- Industry: Special Purpose Equipment Manufacturing
- Address: No. 2930 Nanhuan Road, Binjiang District, Hangzhou City, Zhejiang Province
- Website: www.tailingood.com
- Company Profile: Tailin Bio's predecessor was Hangzhou Tailin Biotechnology Equipment Co., Ltd., established with investment from Ye Dalin and Ye Dafa. The company was transformed into a joint-stock company on April 30, 2015, and was listed on the ChiNext Board of the Shenzhen Stock Exchange on January 14, 2020. The company focuses on the R&D, production, and application of products in microbial detection and contamination control, innovative drug R&D and production, process analysis, and containment protection in the life sciences field.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Qingdao Gaode Investment Partnership (Limited Partnership) | General Legal Person | 606.63 | 7.98 |
| 2 | Zhejiang Tailin Bioengineering Co., Ltd. - 2025 Employee Stock Ownership Plan | Asset Management Plan | 120.80 | 1.59 |
| 3 | Beijing Xijinhui Investment Management Co., Ltd. - Xijinhui Hechuan Securities Private Fund | General Legal Person | 57.70 | 0.76 |
| 4 | CITIC Securities Asset Management (Hong Kong) Limited - Client Funds | Asset Management Plan | 52.82 | 0.69 |
| 5 | UBS AG | QFII | 41.60 | 0.55 |
5. Concept Sectors
- Food Safety
- Intelligent Machines
- Immunotherapy
- Equity Transfer
- Small Cap Non-Margin
- Micro Small Cap Stock
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information